Page last updated: 2024-08-26

sr141716 and Drug Abuse, Intravenous

sr141716 has been researched along with Drug Abuse, Intravenous in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Burbach, JP; Gerrits, MA; Hoogveld, E; Lesscher, HM; van Ree, JM1
Cossu, G; Fattore, L; Fratta, W; Martellotta, CM1

Other Studies

2 other study(ies) available for sr141716 and Drug Abuse, Intravenous

ArticleYear
Endogenous cannabinoids are not involved in cocaine reinforcement and development of cocaine-induced behavioural sensitization.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2005, Volume: 15, Issue:1

    Topics: Analysis of Variance; Animals; Behavior, Animal; Cannabinoid Receptor Antagonists; Cannabinoids; Cocaine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Male; Mice; Mice, Inbred C57BL; Movement; Piperidines; Pyrazoles; Receptors, Cannabinoid; Reinforcement, Psychology; Rimonabant; Self Administration; Substance Abuse, Intravenous

2005
Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats.
    Psychopharmacology, 2001, Volume: 156, Issue:4

    Topics: Analgesics; Animals; Benzoxazines; Cannabinoids; Dose-Response Relationship, Drug; Injections, Intravenous; Male; Morpholines; Naphthalenes; Piperidines; Pyrazoles; Rats; Rats, Long-Evans; Receptors, Cannabinoid; Receptors, Drug; Reinforcement Schedule; Rimonabant; Self Administration; Substance Abuse, Intravenous

2001